Efficacy and Safety of Niraparib Combined With Oral Etoposide in Platinum Resistant/Refractory Recurrent Ovarian Cancer
Condition(s):Ovarian CancerLast Updated:September 1, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Ovarian CancerLast Updated:September 1, 2021Unknown status
Condition(s):Breast CancerLast Updated:December 2, 2020Completed
Condition(s):NK/T Cell LymphomaLast Updated:July 30, 2019Unknown status
Condition(s):Small Cell Lung CancerLast Updated:July 10, 2020Unknown status
Condition(s):Lung CancerLast Updated:February 14, 2024Active, not recruiting
Condition(s):Glioblastoma; GliosarcomaLast Updated:August 12, 2013Completed
Condition(s):Small Cell Lung CancerLast Updated:May 26, 2023Active, not recruiting
Condition(s):Ovarian CancerLast Updated:September 29, 2017Unknown status
Condition(s):Lung CancerLast Updated:August 17, 2017Completed
Condition(s):Extensive Stage Small Cell Lung Cancer; Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:January 9, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.